Monitoring vaccination coverage: Defining the role of surveys. by Cutts, Felicity T et al.
LSHTM Research Online
Cutts, FT; Claquin, P; Danovaro-Holliday, MC; Rhoda, DA; (2016) Monitoring vaccination cov-
erage: Defining the role of surveys. Vaccine, 34 (35). pp. 4103-9. ISSN 0264-410X DOI:
https://doi.org/10.1016/j.vaccine.2016.06.053
Downloaded from: http://researchonline.lshtm.ac.uk/2581835/
DOI: https://doi.org/10.1016/j.vaccine.2016.06.053
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
https://researchonline.lshtm.ac.uk
Review
Monitoring vaccination coverage: Defining the role of surveys
Felicity T. Cutts a,⇑, Pierre Claquin b, M. Carolina Danovaro-Holliday c, Dale A. Rhoda d
a London School of Hygiene and Tropical Medicine, UK
bWorld Health Organization Consultant, Lamballe, France
cWorld Health Organization, Geneva, Switzerland
dBiostat Global Consulting, OH, USA
a r t i c l e i n f o
Article history:
Received 12 November 2015
Received in revised form 13 June 2016
Accepted 16 June 2016
Available online 24 June 2016
Keywords:
Vaccination
Coverage
Surveys
Program monitoring
Health facility surveys
a b s t r a c t
Vaccination coverage is a widely used indicator of programme performance, measured by registries, rou-
tine administrative reports or household surveys. Because the population denominator and the reported
number of vaccinations used in administrative estimates are often inaccurate, survey data are often con-
sidered to be more reliable. Many countries obtain survey data on vaccination coverage every 3–5 years
from large-scale multi-purpose survey programs. Additional surveys may be needed to evaluate coverage
in Supplemental Immunization Activities such as measles or polio campaigns, or after major changes
have occurred in the vaccination programme or its context.
When a coverage survey is undertaken, rigorous statistical principles and field protocols should be fol-
lowed to avoid selection bias and information bias. This requires substantial time, expertise and
resources hence the role of vaccination coverage surveys in programme monitoring needs to be carefully
defined. At times, programmatic monitoring may be more appropriate and provides data to guide pro-
gram improvement. Practical field methods such as health facility-based assessments can evaluate mul-
tiple aspects of service provision, costs, coverage (among clinic attendees) and data quality. Similarly,
purposeful sampling or censuses of specific populations can help local health workers evaluate their
own performance and understand community attitudes, without trying to claim that the results are rep-
resentative of the entire population. Administrative reports enable programme managers to do real-time
monitoring, investigate potential problems and take timely remedial action, thus improvement of admin-
istrative estimates is of high priority. Most importantly, investment in collecting data needs to be com-
plemented by investment in acting on results to improve performance.
 2016 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4104
2. Common goals of vaccination coverage surveys . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4105
3. Are data from coverage surveys accurate? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4105
4. What factors affect the time and other resources needed for vaccination coverage surveys? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4105
5. How often should coverage surveys be done? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4106
6. What alternatives to household surveys are useful for programme managers? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4107
7. Conclusions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4108
Conflict of interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4108
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4108
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4108
http://dx.doi.org/10.1016/j.vaccine.2016.06.053
0264-410X/ 2016 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author at: London School of Hygiene and Tropical Medicine, Keppel St, London WC1E7HT, United Kingdom
E-mail address: felicity.cutts@lshtm.ac.uk (F.T. Cutts).
Vaccine 34 (2016) 4103–4109
Contents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vacc ine
1. Introduction
Vaccination coverage is a widely-used indicator of vaccination
programme strengths and weaknesses and of access to health care
[1,2]. High coverage of the first dose of diphtheria-tetanus-pertussis-
containing vaccine (DTPCV1) indicates good access to primary
health care facilities; by contrast a high proportion of zero-dose
children suggest either low access to services or lack of acceptance
of vaccination. High dropout between early and final doses of the
primary vaccine series may indicate health system barriers to re-
attendance, failure to educate mothers of the need to return, or inad-
equate tracking of children registered at the health facility. Missed
opportunities to administer all vaccines scheduled at the same visit
(‘‘non-simultaneous vaccination”) may indicate vaccine stock-outs,
mistakes in identifying which vaccines are due, reluctance to vacci-
nate a sick child or to administer multiple vaccines at the same visit,
etc. [3–5]. Monitoring the age at receipt of each vaccine-dose (‘‘time-
liness”) helps verify that vaccines are not administered too early,
which might reduce vaccine effectiveness, yet as soon as possible
after the scheduled age to minimize the time that the child is at risk
of infection [1,6–8].
Several methods are used to monitor coverage [9] each having
advantages and disadvantages (Table 1, adapted from [10]). Elec-
tronic vaccination registries can provide continuous data for cover-
age measurement and for management activities such as
monitoring vaccine supply and requisitions and sending vaccina-
tion reminders [11], but there are many challenges to their imple-
mentation [12,13]. Most low-income countries rely on paper-based
systems to report vaccinations administered and divide by the esti-
mated target population to derive ‘‘administrative coverage esti-
mates”. Administrative estimates, however, are often unreliable
due to incomplete or inaccurate primary recording of vaccinations,
mistakes in compiling monthly summaries of vaccinations, delayed
or duplicate reporting and inaccurate estimates of population
denominators [1,14–16].
Household surveys are often proposed because EPI managers or
global partners do not trust administrative reports. Vaccination
coverage is measured in the large-scale Multiple Indicators Cluster
Survey (MICS) [17] and Demographic and Health Survey (DHS) [18]
programmes which use probability sampling methods (i.e. one in
which each individual has a known and non-zero chance of being
selected) and strict quality control with substantial technical
assistance [19]. The Expanded Programme on Immunization (EPI)
cluster survey was developed over 30 years ago as a simple non-
probability sampling method that could be implemented with
little or no technical assistance [20,21]. Although the EPI survey
has been a valuable programme management tool, the use of
non-probability sampling and lack of standardized, well-
documented quality control procedures may reduce confidence
in the results [1,22,23]. The 2015 working draft of the EPI cluster
survey manual recommends using a probability sample (for which
excellent collaboration is needed with the National Statistics or
Census Office to obtain the sampling frame and maps of enumera-
tion areas (EAs)), designing the survey and its sample size accord-
ing to the evaluation goals, conducting appropriately weighted
analyses, rigorous quality control, and fully documenting survey
design and implementation. This will increase the technical and
financial resource needs for vaccination coverage surveys, which
should therefore be used judiciously.
In this paper, we discuss issues that affect decisions to under-
take household surveys and propose some alternative monitoring
methods to answer programme questions at peripheral health
Table 1
Advantages and disadvantages of methods to measure vaccination coverage.
Method Advantages Disadvantages
Register-based
(electronic)
Can give complete and accurate real-time data on cumulative
vaccination status of individual persons and populations
Can be used to set appointments and issue reminders and
recalls
Can be used for vaccine stock control, ordering and
accountability
Could reduce time spent on paper registers that are
widespread in low-income countries and often not used
Can facilitate printing or electronic access to home-based
vaccination records
Can provide data at most peripheral operational level
Need good computer access
Need complete birth registry for true denominator
Need unique ID number throughout life
Need procedures to identify and deal with potential duplicate records
If held locally, difficult to track vaccination of migrants
If held nationally, feedback/use at local level may be slow
Requires adequate funding for proper maintenance
Need sufficient, well-trained human resources at each level of the reporting
system
Need secure procedures to maintain confidentiality
Need procedures to avoid losing data
Difficult to use to measure coverage in SIAs
Routine reports of
vaccinations
delivered
Can be simple in conception
Continuous information allows monitoring of cumulative
coverage through the year and by district/health facility
Can be used by local health workers to track coverage, missed
opportunities, and dropout rates
Usually part of a routine reporting system used for multiple
health programmes
Population denominators often inaccurate, especially at local levels
Private sector often does not report
Exaggeration of doses administered common, especially when linked to
performance-based incentives
Transcription errors at each health system level when paper-based systems used
In SIAs, reports often give inflated estimates due to short time for recording, and
vaccination of persons outside the target age group
Community-based
surveys
If well-conducted, evaluate coverage in routine services and/
or in SIAs
Other indicators (eg, missed opportunities, caretaker
demographics and knowledge/attitudes) can be assessed
although this increases questionnaire length and complexity
Can be used to classify coverage e.g. as ‘‘probably high”,
‘‘probably low” or ‘‘indeterminate” in subnational areas and
highlight those with lowest coverage
Can allow estimation of coverage in specific sub-groups if
designed appropriately
Involvement of health workers can be training opportunity
Accessibility to populations to survey depends on geographic, climatic and
security issues, and high-risk subgroups (e.g., migrants, street children) often
missed, compromising representativeness of survey results
Small samples give imprecise results; large samples are expensive and field work
takes longer
In some settings, it may be difficult to obtain accurate ages/dates of birth
Accuracy of data depends on adequate survey design, training, supervision, and
quality control, as well as availability of vaccination documentation
Information bias likely if documents are missing, incomplete or inaccurate –
verbal history increasingly difficult as more vaccines included in programmes
under a range of different schedules
Often subcontracted to private organisation hence health worker training
opportunity lost
Often long delays until results are known, and survey data relate to birth cohort
at least one year prior to survey implementation
Adapted from Table 70-3 in [10].
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system levels. Unless otherwise specified, we use the term
household surveys when referring to community-based surveys
using probability sampling.
2. Common goals of vaccination coverage surveys
In the past, surveys have been conducted frequently to monitor
trends in national routine vaccination coverage. By 2013, however,
many countries had reached over 85% coverage, beyond which
annual increases will be small and DHS or MICS are conducted
often enough to monitor changes. A large proportion of countries
where coverage is still low are affected by conflict which inhibits
both vaccination and the conduct of surveys representing the
entire population of the country. Therefore, surveys with a primary
goal of measuring routine immunization (RI) coverage at national
level will either rarely be needed or not be feasible. By contrast,
evaluation of coverage achieved in Supplemental Immunization
Activities (SIAs), for example those used to introduce rubella vac-
cine in developing countries, is becoming more important [24].
Other goals of coverage surveys include comparing coverage in
different provinces of a country, evaluating the coverage of vacci-
nes recently introduced into the national immunization pro-
gramme, and evaluating coverage in certain areas of the country
selected e.g. because they have been targeted by specific interven-
tions, or are recovering from natural or man-made disasters.
Although data are desirable at the most peripheral levels, house-
hold surveys are too time-and resource-intensive to conduct in
every district and other monitoring methods are more suitable at
district level. One possibility is to conduct surveys that provide
imprecise estimates in each district but have adequate size to clas-
sify coverage as likely to be very low or very high, and to aggregate
the data from each district as a stratified sample to obtain esti-
mates with reasonable precision at the next-higher level e.g.
provincial level and with very tight precision at national level. In
this document when we say ‘‘useful to classify”, we mean a sample
too small for precise estimation at the peripheral level, but proba-
bly useful for distinguishing very poor and very good performance
and also useful for aggregation up to higher levels of hierarchy.
3. Are data from coverage surveys accurate?
Coverage estimates from surveys are often trusted more than
administrative estimates [16] but, like administrative estimates,
their accuracy depends in part on the quality of primary recording
of vaccinations. In addition, surveys are subject to other types of
information bias, selection bias and sampling error [1,25].
Selection bias can occur when the list of eligible respondents
(the sampling frame) excludes subpopulations (e.g. in conflict set-
tings, or areas with large homeless populations), when field proce-
dures use non-probability sampling methods or substitute a
sampled household with one which is easier to reach, or when
revisits to households where a respondent was initially absent
are not done or unsuccessful. The populations likely to be missed
in a vaccination coverage survey are also likely to be missed by
vaccination teams, so selection bias most often inflates coverage
estimates.
Information bias occurs when a child’s vaccination status is
misclassified due to mistakes in the vaccination record, transcrip-
tion of data from the record, or the guardian’s recall for children
without a written record (which may be affected by the way the
interviewer asks the questions and the complexity of the vaccina-
tion schedule). It can bias results upwards or downwards, in part
depending on the degree to which the respondent perceives social
pressure to report complete vaccination [26,27]. The number of
vaccines in national schedules in developing countries has more
than doubled since 1980 with a consequent increase in the burden
of recording on home-based and health-facility-based records. The
2015 WHO EPI manual recommends that when a home-based
record is unavailable, documents should be sought at health facil-
ities, but the extent to which this will be feasible and the improve-
ment in quality gained with its implementation in different
countries is as yet unknown. Information bias may still occur
because documents are missing or contain errors [1].
4. What factors affect the time and other resources needed for
vaccination coverage surveys?
EPI coverage surveys using probability samples are expected to
take at least 12 months between inception and the final report
(Table 2). The timeframe may be shorter for a post-SIA survey if
data are only needed at national level and only vaccines adminis-
tered in the SIA are assessed. Surveys should be planned well in
advance, and for post-SIA surveys, planning should start concur-
rently with preparation for SIA implementation. The length of the
planning phase depends in part on financing and sub-contracting
mechanisms, as well as the time needed to obtain ethical clear-
ance, census data, maps, and resources. The timeframe for the sur-
vey must be realistic taking into account the feasibility of ensuring
that all field workers follow protocol properly. It is better to work
with 30 excellent field workers than 300 poor or mediocre field
workers, and to ensure that all teams are well supervised and qual-
ity control is rigorous. Factors affecting the human, financial and
logistical resources as well as the time needed to implement a sur-
vey include (but are not limited to):
 Whether the goals are estimation of coverage (and with what
precision) or classification of coverage as probably high, proba-
bly low, or intermediate (and with what tolerance of the chance
of misclassification). It may be more practical to aim to classify
coverage at sub-national levels and roll-up the data to estimate
coverage precisely at national level than to try to estimate cov-
erage at each sub-national level.
 For hypothesis testing, how narrow a difference between
groups is to be detected, with what power and at what signifi-
cance level.
 The number of strata. Resource needs increase proportionately
to the number of sub-national strata where results are reported.
For example, compared to a single national estimate of a given
precision (e.g. ±5%), in a country that has 10 provinces, each
with 10–17 districts (total of 150 districts in the country), the
sample size would increase 10-fold if survey results of precision
±5% are desired in all provinces, and 150-fold if district-level
estimates of ±5% are desired.
 The number of age cohorts for which results are desired – e.g.
stratifying SIAs that target children up to 15 years to estimate
coverage by 5 year age groups increases the sample size com-
pared to a single estimate for all persons under age 15 years.
If a survey is already stratified by province, it may be best to
aim to obtain data by age-group at national level, where the
total sample size rolled-up from all provinces is much higher.
 The number of health topics evaluated in the survey, as sample
size requirements vary for different indicators, and the more
health topics, the longer the questionnaire. Furthermore, long
questionnaires may also affect the quality of the data on each
topic due to interviewer and respondent fatigue.
Note especially the implications of evaluating routine vaccina-
tion coverage during a post-SIA survey. For the same target preci-
sion, the required sample size is higher for routine than for SIA
coverage because coverage in the former is usually lower and more
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heterogeneous. This is compounded by the need to visit more
households to find eligible persons because routine coverage is
assessed in a much narrower age group than SIA coverage (e.g.
see Table 3). Furthermore, the questionnaire is much longer for
RI because there are now more than 20 potential vaccine-dose
combinations in the routine vaccination schedule to record, and
health facilities should be visited if the child’s caregiver cannot fur-
nish a home-based record, whereas SIA vaccination is not recorded
in health facilities so such visits are not recommended. Thus, eval-
uating all routine vaccinations among 12–23 month olds during a
post-SIA survey increases resource needs and may delay results
of SIA coverage. It will often be best to focus resources on ensuring
optimal supervision during the SIA and obtaining timely, high-
quality SIA coverage data. One or two questions can be included
about prior receipt of the relevant vaccine (e.g. measles-
containing vaccine if a measles or measles-rubella SIA is being
evaluated) through routine services so as to evaluate whether the
SIA reached persons missed by the routine programme.
5. How often should coverage surveys be done?
The frequency of surveys depends on how likely it is that results
have changed since the last high quality survey in the same area,
which in turn relates to the level of coverage in the last survey,
the timing of any interventions conducted to increase coverage,
and the extent of changes in health system or political context that
may affect coverage. It also depends on progress in improving
administrative data.
In countries with sustained high routine coverage (e.g. WHO-
UNICEF estimates of DTPCV3 85% or above), it becomes more diffi-
cult to identify a statistically significant increase – in fact, by
Table 2
Illustrative timeframe for a probability sample household coverage survey.
Stage Activity Dates
Planning and survey
preparation
Form steering committee and technical subcommittees, identify implementing
agency, agree on methods to recruit field coordinators, supervisors and interviewers,
agree on use or not of digital technology for data collection, identify technical
assistance if required, set up liaison with statistics or census office, order and obtain
supplies & identify transport
Months 1–4 (may take longer if Request for
Proposals issued for selection of implementing
agency, if complex survey design with multiple
indicators, depending on ethics committee
procedures and timetable, and depending on time
needed to obtain and release funding)Survey design and modification to fit resource availability
Obtain funding for the survey
Obtain ethical review as required
Sample selection (including obtaining enumeration area-EA maps)
Visit health facilities in the areas selected for the survey to explain survey and obtain
co-operation
Questionnaire design, pretest and translation
Preparation of digital entry procedures, if used
Pretest household sampling procedures
Preparation of manuals/standard operating procedures
Preparation of training site(s) and materials
Preparation of database
Training Train field workers and supervisors: household listing, collection of GIS coordinates,
conducting interviews, getting data from health facilities, checking completed
questionnaires, digital data entry where relevant, ensuring SOPs are followed
Month 5 (longer for large surveys; allow 2 weeks
for every 30 field staff being recruited)
Train data entry staff if paper forms are used
Data collection Mapping and household listing
Collection of data from eligible persons with revisits as needed
Quality control in the field, including random revisits by supervisors
Resolution of queries
Months 6 (if small survey), or 6–8 (for survey with
multiple strata)
Data management and
analysis
Data double-entry and editing (if paper forms used) Months 6–7 (small survey) or 6–9 (large survey)
Final data checking and cleaning
Data analysis, produce tables and graphs
Report generation and
dissemination
Preparation/review of preliminary report Months 10–12 (may be sooner if small and focused
survey is done)Prepare final report, with summary of key findings
National feedback and develop action plan
Prepare reports/fact sheets for health workers
Workshops with health workers at sub-national levels
Table 3
Sample size and number of households that must be visited in a post-SIA survey with and without inclusion of routine immunization (RI) coverage assessment.
N (Completed Interviews) HH (Households to Visit)
Expected
Coverage
Post-SIA Alone RI DTPCV3 12-23m
Width of confidence intervals:
Post-SIA Alone RI DTPCV3 12-23m
Width of confidence intervals:
SIA RI ±3% ±3% ±5% ±10% ±3% ±3% ±5% ±10%
95% 90% 708 1554 645 210 1416 7770 3225 1050
95% 85% 708 1989 795 240 1416 9945 3975 1200
95% 75% 708 2676 1020 285 1416 13,380 5100 1425
90% 60% 1036 3291 1203 309 2072 16,455 6015 1545
SIA = Supplemental Immunization Activity; RI = Routine Immunization; DTPCV3 = 3 Doses of Diphtheria Tetanus Pertussis Containing Vaccine.
Notes: This table assumes a post-SIA design effect of 2.0 and an RI design effect of 3.0, as intracluster correlation is expected to be higher for the latter. It also assumes that
eligible respondents for post-SIA survey are 9m-15y of age and that it will be necessary to visit two households, on average, to find each eligible and cooperative respondent.
Eligible RI respondents are 12–23 m of age and it will be necessary to visit 5 households, on average, to find each eligible and cooperative respondent.
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chance one could see a fall in the point estimate which could dis-
courage health workers who do not understand sampling error.
SIAs are done less frequently than in countries with low RI cover-
age [24] and nationwide surveys will therefore be needed infre-
quently. Surveys may be done at sub-national level, e.g. to
evaluate interventions in specific areas of the country where cover-
age had been lower than average.
Countries with coverage below 80% still need to achieve large
gains to reach goals such as those in the Global Vaccine Action Plan
[2], thus surveys can be useful to monitor trends. Their role may be
limited, however, by conflict which affects almost half the coun-
tries with median WHO-UNICEF coverage estimates of DTPCV3
below 80% from 2011–2013 [28]. Surveys can help to measure cov-
erage in the more secure areas but trends may be difficult to inter-
pret if different parts of the country are accessible in each survey.
When programmes are weak and/or there is marked internal pop-
ulation displacement, documentation of vaccination status is
harder to obtain, further reducing the reliability of survey data.
Although administrative data are also inaccurate in many of these
countries, routine information on programme inputs and process
indicators such as number of vaccination sessions held, number
of outreach sessions held on time, number of vaccine stock-outs,
etc., plus health facility surveys (see below) and rapid convenience
monitoring [9] in accessible areas, can provide insights to improve
programme performance.
6. What alternatives to household surveys are useful for
programme managers?
Before considering a new survey, existing data should be
reviewed to assess whether there is enough information to take
programme decisions. For example, because administrative reports
most often tend to over-estimate than under-estimate coverage
[16], if administrative estimates show low national coverage of
first dose DTPCV, and there is no major under-reporting of vaccina-
tion (e.g. if a large private sector does not report) or evidence of a
markedly inflated denominator, then coverage is likely to be truly
low. It may be more important to investigate and address the rea-
sons for low coverage than to do a survey to verify precisely how
low coverage is. Reasons for low access to or use of vaccination ser-
vices can be assessed by reviewing information on service delivery
from reports of supervisory visits, recent programme reviews and
supply chain assessments. Formative research such as focus groups
and key informant interviews with health workers, community
leaders, and community groups provides insights to help local pro-
gramme managers modify delivery strategies appropriately.
If administrative reports and/or recent surveys show high drop-
out rates, then reasons should be investigated. Coverage surveys
measure the extent of dropout and non-simultaneous vaccination
but not their causes and hence do not inform the design of strate-
gies to reduce them (Table 4). Health-facility surveys (including
outreach sites) are very useful to assess multiple aspects of service
delivery including missed opportunities and their causes [29,30],
vaccine supply chain, tracking activities and health worker knowl-
edge, attitudes and practice about vaccination and safe injections
(Table 4). The costs of each aspect of service provision can also
be estimated. The human factor in providing vaccination services
(absenteeism, quality of training, wrong interpretation of con-
traindications, etc.) should be carefully assessed. The quality of
data recording can be evaluated by comparing data from home-
based records reviewed during exit interviews with data from
clinic registers for the same children, and comparing register data
with reports to higher levels [31,32]. Although health facility sur-
veys do not provide data that represents the entire population
(or even all health facilities, depending on whether facilities are
selected purposefully or randomly), and are subject to observer
bias if the presence of an interviewer at the health facility affects
the way the health workers perform on that day, they often iden-
tify problems with health service provision. Results can be consid-
ered a ‘‘best case” scenario and interventions to improve services
undertaken soon after the surveys are completed.
Health facility surveys can be combined with other methods
that district health personnel can conduct with minimal external
support, such as ‘‘100 household surveys” (later termed ‘‘75 house-
hold surveys”) in which households closest to a health facility are
Table 4
Choice of methods according to the purpose of monitoring.
Monitoring/evaluation
purpose
Cluster survey with probability sampling and excellent quality
control
Health facility-based surveys
(note: results refer only to
persons using the facilities
sampled)
Purposeful sampling or
censuses of selected
populations
National Every province Selected
provinces/districts
To measure coverage in an SIA
at national level
Yes Yes No No No
To evaluate SIA coverage at
national and sub-national
levels
No Yes No No No
To measure national routine
vaccination coverage
Yes Yes No No No
To measure routine coverage
at sub-national levels
No Yes, though not
feasible in all
districts
Yes, for selected
areas only
No Yes, in the areas included,
with no sampling error
To classify coverage at sub-
national levels
No Yes Yes, for selected
areas only
Yes, among children who’ve
received DTPCV1
Not relevant
To determine if an
intervention has
successfully increased
coverage
Possibly, if sample size
adequate (based on
baseline and follow-up
sample precision)
Yes, if sample size adequate to detect
the difference. Especially useful if some
areas had the intervention while others
did not, and if baseline and post-
intervention are available for areas with
and without the intervention
Can assess if an intervention has
increased coverage of
subsequent vaccines among
children who have received
DTPCV1
Theoretically possible, but
probability samples of
larger areas usually
preferred
To assess dropout, timeliness,
missed opportunities
Can measure dropout and missed opportunities but does not assess
their health-system causes
Can assess both prevalence and
causes
Can assess prevalence in the
areas canvassed
To identify reasons for lack of
receipt of DTPCV1
Yes if suitable questions added to the survey, ideally informed by
prior qualitative research (and need appropriate sample size
calculations for hypothesis testing), but does not directly evaluate
health system barriers
Can assess health system
barriers to attendance (e.g.
vaccine stock-outs, health
worker absence)
Yes, but only in the areas
canvassed
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canvassed and vaccination status assessed for children aged 12–23
months together with caretaker and community opinions about
vaccination services [29,33]. Although the 100-household survey
is a purposeful sample and is not generalizable to households
farther from the health facility, it is useful to determine reasons
for incomplete or delayed vaccination among persons with good
physical access to health facilities. A similar purposeful sampling
method to check vaccination status of all individuals in the target
age groups of interest could be implemented in villages far (e.g.
>5 km) from a health facility or outreach site. Such ‘‘mini-
censuses” can be done by local healthworkers in areas that for com-
mon sense reasons are thought likely to have lower coverage. Such
censuses should cover the entire population of those areas and not
only assess vaccination coverage but also identify and refer infants
who are behind on vaccination (and other health needs can be
assessed during the same visits). They could be done on a rolling
basis to cover many areas over the course of the year. These kinds
of community-based activities involving door-to-door visits and
community discussions should become part of an ongoing process
of community engagement in planning, implementing and moni-
toring vaccination services. Although not based on random samples
and therefore not providing robust estimates of average district
coverage, they are valuable learning tools for health workers and
provide in-depth information on entire population subgroups
which is more easily understood by communities and health work-
ers (since ALL residents of the given areas are canvassed). This
should more easily lead to local action to improve services [9].
7. Conclusions
Coverage surveys have played an important role in helping
countries monitor progress of vaccination programmes, but their
role is changing as many programmes have matured. Surveys have
an important role to evaluate SIA coverage, where reported cover-
age is particularly likely to be inaccurate because during SIAs there
is little time to check the age or residency of persons attending for
vaccination or to record and report vaccinations accurately. For
routine vaccination coverage, DHS and MICS will usually be suffi-
cient to monitor trends at national and often also provincial levels.
Donors may desire a coverage survey because they lack confi-
dence in administrative estimates, but the likelihood that accurate
and representative results can be obtained through household sur-
veys at reasonable cost needs to be assessed carefully. For example,
if major areas of the country are inaccessible due to insecurity then
results will not represent the whole country; if there have been
known stock-outs of home-based vaccination records, and health
facility registers are poorly filled in or difficult to access, then infor-
mation bias will be difficult to avoid. How the results will help
managers at different levels to improve their programmes should
be assessed. Surveys can always give ‘‘some useful information”
but there will often be quicker and cheaper ways for programme
managers to get more actionable information, including health
facility assessments and purposive sample surveys.
If a coverage survey is done, it is important to define and prior-
itize objectives clearly for each geographical level, with realistic
assessment of the required resources and time for different poten-
tial objectives and compromise on the goals of the survey if needed
to ensure it will have excellent quality with the available
resources. The survey must be implemented according to protocol,
with strict quality control of all aspects of sampling, data collec-
tion, management and analysis. Results should be translated into
information that leads to action, with feedback at all health system
levels. The links built with statistics or census offices for surveys
should be expanded on, e.g. using population data and maps to
improve district-level planning.
At sub-national level, in most instances, simpler methods will
be suitable for programme needs. Health facility assessments
should be conducted regularly and can be complemented by cen-
suses of vaccination status, knowledge, attitudes and practices
among neighbourhoods and villages near to and far from sites
offering vaccination. These can be planned, implemented and ana-
lyzed by district health staff, thus maximizing the learning experi-
ence, and their results are available at the local level very quickly
thus facilitating action.
The resources that would be required for household probability
sample surveys will often be better invested in supporting locally-
led monitoring and acting to strengthen routine reporting systems,
especially the primary recording of data, which would improve
both administrative estimates and future survey estimates. Most
importantly, investment in collecting data needs to be comple-
mented by investment in acting on results to improve programme
performance.
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